Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
erectile dysfunction
Biotech
Cash-depleted Acerus undergoes strategic review
Sexual-health-focused Acerus is undergoing a strategic review as it looks to keep its head above water amid mounting financial concerns.
Max Bayer
Sep 21, 2022 10:45am
How Viagra could boost a widely used blood cancer treatment
Oct 10, 2019 11:00am
Sheep study shows Eli Lilly's Cialis might reverse heart failure
May 2, 2019 10:11am
Cytori rises on data for erectile dysfunction cell therapy
Jul 9, 2018 9:16am
Apricus craters as FDA rejects ED cream again
Feb 16, 2018 9:00am
